Illicit Drugs as Emerging Contaminants

被引:0
|
作者
Castiglioni, Sara [1 ]
Zuccato, Ettore [1 ]
机构
[1] Mario Negri Inst Pharmacol Res, Dept Environm Hlth Sci, I-20156 Milan, Italy
关键词
SOLID-PHASE EXTRACTION; PERSONAL CARE PRODUCTS; URBAN WASTE-WATER; SURFACE-WATER; STIMULATORY DRUGS; MASS-SPECTROMETRY; ABUSE; COCAINE; METABOLITES; PHARMACEUTICALS;
D O I
暂无
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Illicit drugs were recently indicated as emerging contaminants since they have been detected in waste, surface and drinking water and in the airborne particulates in several European countries and USA. In analogy with pharmaceuticals, the main source of contamination for illicit drugs is human consumption. The residues of drugs of abuse persisting in consumers' urine can reach sewage treatment plants (STPs) in detectable amounts, escaping degradation, and can be released into surface water. The first investigations of illicit drugs in the environment were carried out in U.S.A. in 2004 for amphetamines, and in Italy in 2005 for cocaine and its main urinary metabolite (benzoylecgonine, BE). Several other substances were later measured in water and air, including cannabinoids, cocaine and its metabolites, opioids, amphetamines, ephedrine, ketamine, lysergic acid diethylamide (LSD), and some related opioid pharmaceuticals. The first step to measure illicit drugs in the environment consists in the preconcentration of analytes operated mainly by solid phase extraction (SPE). Considering the complexity of the environmental matrices and the low concentrations of the analytes, mass spectrometry is the most powerful technique to detect illicit drugs simultaneously with high specificity and accuracy. Therefore, the technique used most frequently is high-pressure liquid chromatography tandem mass spectrometry (HPLC-MS-MS). Illicit drugs were frequently detected at concentrations up to the mu g/L range in STP influents (untreated wastewater) in Europe and U.S.A. Cocaine and its major metabolite BE were investigated in the largest number of countries (Spain, Italy, Switzerland, UK, Belgium, Germany, Ireland and U.S.A.), and were the most abundant compounds. Other substances measured at high concentrations were several stimulatory drugs, including amphetamines and ephedrine, opioids, and the main metabolite of cannabis, 11-nor-9-carboxy- Delta 9-THC (THC-COOH). Despite the fact that illicit drugs are generally well removed in STPs (removal higher than 60%), several substances were still detected at concentrations up to the hundreds of ng/L in STPs effluents. Treated wastewater is generally discharged into surface water (rivers, lakes, sea) or undergoes further treatment to produce drinking water. Substantial amounts of illicit drugs therefore direclty enter surface water or drinking water treatment plants. These substances were still detectable in rivers and lakes up to tenths of ng/L in several countries, and trace amounts of BE, methadone and its main metabolite, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), were still present in finished drinking water in a Spanish drinking water treatment plant. Traces of illicit drugs were also detected in airborne particulate in several of the world's cities, indicating the possible distribution of these substances in the air compartment, despite their polarity and high water solubility. The amounts of illicit drugs detected in wastewater could roughly reflect the amounts consumed. Our group recently proposed a novel approach (sewage epidemiology) for estimating drug consumption in a community by the direct measurement of the residues of the illicit drugs in urban wastewater. This method can give evidence-based estimates of drug use in a defined area with the unique ability to monitor local consumption in real time and promptly identify changes.
引用
收藏
页码:119 / 136
页数:18
相关论文
共 50 条
  • [21] Injecting illicit drugs
    Finch, Emily
    [J]. ADDICTION RESEARCH & THEORY, 2006, 14 (05) : 555 - 556
  • [22] REPORT ON DRUGS, ILLICIT
    CLARK, CC
    [J]. JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS, 1985, 68 (02): : 234 - 234
  • [23] ILLICIT DRUGS OF ABUSE
    SCHULZ, JE
    [J]. PRIMARY CARE, 1993, 20 (01): : 221 - 230
  • [24] ANALYSIS OF ILLICIT DRUGS
    KOK, JCF
    FROMBERG, E
    GERRLING.PJ
    VANDERHL.HJ
    KAMP, PE
    VANDERSL.EP
    WILLEMS, MAM
    [J]. LANCET, 1971, 1 (7708): : 1065 - &
  • [25] ILLICIT USE OF DRUGS
    FRANKFORD, RT
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1979, 120 (01) : 19 - 19
  • [26] Illicit drugs in schizophrenia
    Macleod, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S184 - S184
  • [27] Collaborative surveillance and public health responses to illicit and emerging drugs in New South Wales
    Atefi, David
    Ashworth, Gail
    Auld, Robin
    Brouwer, Isabel
    Buckley, Nicholas
    Chan, Trevor
    Cretikos, Michelle
    Cullinan, Una
    Dawson, Andrew
    Dunlop, Adrian J.
    Ezard, Nadine
    Gill, Tony
    Gunja, Naren
    Harrod, Mary Ellen
    Harvey, Christine
    Capell-Hattam, Thomas
    Henderson, Charles
    Ionmhain, Una Nic
    Jiranantakan, Thanjira
    Madeddu, Daniel
    McDonald, Catherine
    Neville, Sharon
    O'Sullivan, Teresa
    Du Toit-Prinsloo, Lorraine
    Roberts, Darren
    Ryan, Therese
    Seyfang, Kelsey
    Shaw, Vanessa
    Symonds, Michael
    Tran, Jason
    Turner, Claire
    Vazquez, Santiago
    Zador, Deborah
    Brown, Jared
    [J]. DRUG AND ALCOHOL REVIEW, 2023, 42 : S31 - S32
  • [28] Illicit drugs and seizures
    Smith, PEM
    McBride, A
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 1999, 8 (08): : 441 - 443
  • [29] On the economics of illicit drugs
    Van Ours, Jan C.
    Pudney, Stephen
    [J]. ECONOMIST-NETHERLANDS, 2006, 154 (04): : 483 - 490
  • [30] Injecting illicit drugs
    Belcher, J
    [J]. DRUG AND ALCOHOL REVIEW, 2006, 25 (03) : 290 - 290